Elastase, human leucocytes
Modify Date: 2024-01-10 20:45:17
Elastase, human leucocytes structure
|
Common Name | Elastase, human leucocytes | ||
|---|---|---|---|---|
| CAS Number | 9004-06-2 | Molecular Weight | 326.476 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 495.1±45.0 °C at 760 mmHg | |
| Molecular Formula | C21H30N2O | Melting Point | N/A | |
| MSDS | USA | Flash Point | 253.3±28.7 °C | |
Use of Elastase, human leucocytesElastase is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
| Name | Elastase |
|---|---|
| Synonym | More Synonyms |
| Description | Elastase is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
|---|---|
| Related Catalog |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 495.1±45.0 °C at 760 mmHg |
| Molecular Formula | C21H30N2O |
| Molecular Weight | 326.476 |
| Flash Point | 253.3±28.7 °C |
| Exact Mass | 326.235809 |
| LogP | 7.57 |
| Appearance of Characters | lyophilized powder |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.588 |
| Storage condition | −20°C |
| Hazard Codes | B |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
Prolonged exposure to neutrophil extracellular traps can induce mitochondrial damage in macrophages and dendritic cells.
Springerplus 4 , 161, (2015) Neutrophils are one the earliest, crucial innate defenses against innumerable pathogens. Their main microbicidal activities include phagocytosis and degranulation, with many pharmacologically active m... |
|
|
Clinically relevant cell sources for TMJ disc engineering.
J. Dent. Res. 87 , 548-52, (2010) Tissue-engineering of the temporomandibular joint (TMJ) disc aims to provide patients with TMJ disorders an option to replace diseased tissue with autologous, functional tissue. This study examined cl... |
|
|
Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity, and mechanism-based inhibitors.
Biochemistry 28(5) , 1951-63, (1989)
|
| N-Heptyl-6-methoxy-1,2,3,4-tetrahydro-9-acridinamine |
| 9-Acridinamine, N-heptyl-1,2,3,4-tetrahydro-6-methoxy- |
| N-heptyl-6-methoxy-1,2,3,4-tetrahydroacridin-9-amine |
| EINECS 232-670-7 |